Adherence to care plan in women with abnormal papanicolaou smears: A review of barriers and interventions

Journal of the American Board of Family Practice

Volumn 14, Issue 2, 2001, Pages 123-130

  Khanna, Niharika ^a   Phillips, Mark D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASE MANAGEMENT; DISEASE COURSE; FEMALE; GENERAL PRACTICE; HUMAN; PATHOLOGY; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; REMINDER SYSTEM; REVIEW; SOCIOECONOMICS; UNITED STATES; UTERINE CERVIX; UTERINE CERVIX TUMOR; VAGINA SMEAR;

CASE MANAGEMENT; CERVIX UTERI; DISEASE PROGRESSION; FAMILY PRACTICE; FEMALE; HUMANS; PATIENT COMPLIANCE; REMINDER SYSTEMS; SOCIOECONOMIC FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0035287381     PISSN: 08938652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33
2. SEER cancer statistics review. Tables and graphs. Bethesda, Md: Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1993.
3. Lieu D. The Papanicolaou smear: its value and limitations. J Fam Pract 1996;42:391-9.
4. Breast and cervical cancer screening among underserved women. Baseline survey results from six states. National Cancer Institute Cancer Screening Consortium for Underserved Women. Arch Fam Med 1995;4:617-24.
5. Evaluation of cervical cytology summary. Rockville, Md: Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1999. (Evidence report/technology assessment, no 5. AHCPR publication no. 99-E009.)
6. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989;261: 737-43.
7. Koss L. Cervical (Pap) smear. New directions. Cancer 1993;71:1406-12.
8. Screening for Cervical Cancer. In: Guide to Clinical Preventive Services: report of the US Preventive Services Task Force. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1996.
9. Schofield MJ, Sanson-Fisher R, Halpin S, Redman S. Notification and follow-up of Pap test results: current practice and women's preferences. Prev Med 1994;23:276-83.
10. Lerman C, Hanjani P, Caputo C, et al. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol 1992;10:330-3.
11. Stewart DE, Buchegger PM, Lickrish GM, Sierra S._ The effect of educational brochures on follow-up compliance in women with abnormal Papanicolaou smears. Obstet Gynecol 1994;83:583-5.
12. Marcus AC, Kaplan CP, Crane LA, et al. Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives. Med Care 1998;36:397-410.
13. Prislin MD, Dinh T, Giglio M. On-site colposcopy services in a family practice residency clinic: impact on physician test-ordering behavior, patient compliance, and practice revenue generation. J Am Board Fam Pract 1997;10:259-64.
14. Paskett ED, Phillips KC, Miller ME. Improving compliance among women with abnormal Papanicolaou smears. Obstet Gynecol 1995;86:353-9.
15. Miller SM, Siejak KK, Schroeder CM, Lerman C, Hernandez E, Helm CW. Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy. J Natl Cancer Inst 1997;89:703-8.
16. Paskett ED, White E, Carter WB, Chu J. Improving follow-up after an abnormal Papanicolaou smear: a randomized controlled trial. Prev Med 1990;19:630-41.
17. McKee MD, Lurio J, Marantz P, Burton W, Mulvihill M. Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center. Arch Fam Med 1999;8:129-34.
18. Michielutte R, Diseker RA, Young LD, May WJ. Noncompliance in screening follow-up among family planning clinic patients with cervical dysplasia. Prev Med 1985;14:248-58.
19. Laedtke TW, Dignan M. Compliance with therapy for cervical dysplasia among women of low socioeconomic status. South Med J 1992;85:5-8.
20. Eger RR, Peipert JF. Risk factors for noncompliance in a colposcopy clinic. J Reprod Med 1996;41:671-4.
21. Gilbert TJ, Sugarman JR, Cobb N. Abnormal Papanicolaou smears and colposcopic follow-up among American Indian and Alaska Native women in the Pacific northwest. J Am Board Fam Pract 1995;8: 183-8.
22. Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract 1993;37:583-7.
23. Lane DS. Compliance with referrals from a cancer-screening project. J Fam Pract 1983;17:811-7.
24. Mitchell H, Medley G. Adherence to recommendations for early repeat cervical smear tests. BMJ 1989; 298:1605-7.
25. Elwood JM, Cotton RE, Johnson J, Jones GM, Curnow J, Beaver MW. Are patients with abnormal cervical smears adequately managed? Br Med J (Clin Res Ed) 1984;289:891-4.
26. Ronco G, Iossa A, Naldoni C, et al. A first survey of organized cervical cancer screening programs in Italy. GISCi working group on organization and evaluation. Gruppo Italiano Screening Citologico. Tumori 1998;84:624-30.
27. Ellman R. Problems of follow-up for abnormal cervical smears: discussion paper. J R Soc Med 1990;83: 94-5.
28. Kinlen LJ, Spriggs AI. Women with positive cervical smears but without surgical intervention: A follow-up study. Lancet 1978;2:463-5.
29. Brown RK, Barker WH Jr. Pap smear screening and invasive cervical cancer. J Fam Pract 1982;15:875-9.
30. Carmichael JA, Jeffrey JF, Steele HD, Ohlke ID. The cytologic history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol 1984;148:685-90.
31. Ellman R, Chamberlain J. Improving the effectiveness of cervical cancer screening. JR Coll Gen Pract 1984;34:537-42.
32. Paskett ED, Carter WB, Chu J, White E. Compliance behavior in women with abnormal Pap smears. Developing and testing a decision model. Med Care 1990;28:643-56.
33. Lauver D, Rubin M. Message framing, dispositional optimism, and follow-up for abnormal Papanicolaou tests. Res Nurs Health. 1990;13:199-207.
34. Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 1991;165:658-62.
35. Marcus AC, Crane LA, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care 1992;30: 216-30.
36. Funke BL, Nicholson ME. Factors affecting patient compliance among women with abnormal Pap smears. Patient Educ Couns 1993;20:5-15.
37. Quilliam S. Emotional aspects of positive smears. Health Visit 1989;62:308-9.
38. Lerman C, Rimer BK, Engstrom PF. Cancer risk notification: psychosocial and ethical implications. J Clin Oncol 1991;9:1275-82.
39. Reelick NF, de Haes WF, Schuurman JH. Psychological side-effects of the mass screening on cervical cancer. Soc Sci Med 1984;18:1089-93.
40. Campion MJ, Brown JR, McCance DJ, et al. Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol 1988;95:175-81.
41. McDonald TW, Neutens JJ, Fischer LM, Jessee D. Impact of cervical intraepithelial neoplasia diagnosis and treatment on self-esteem and body image. Gynecol Oncol 1989;34:345-9.
42. Marteau TM, Walker P, Giles J, Smail M. Anxieties in women undergoing colposcopy. Br J Obstet Gynaecol 1990;97:859-61.
43. Boag FC, Dillon AM, Catalan J, Edwards R, Barton SE. Assessment of psychiatric morbidity in patients attending a colposcopy clinic situated in a genitourinary medicine clinic. Genitourin Med 1991; 67:481-4.
44. Palmer AG, Tucker S, Warren R, Adams M. Understanding women's responses to treatment for cervical intra-epithelial neoplasia. Br J Clin Psychol 1993;32(Pt 1):101-12.
45. Bennetts A, Irwig L, Oldenburg B, et al. PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal Pap smear. Psychosocial Effects of Abnormal Pap Smears Questionnaire. J Clin Epidemiol 1995;48:1235-43.
46. Block B, Branham RA. Efforts to improve the follow-up of patients with abnormal Papanicolaou test results. J Am Board Fam Pract 1998;11:1-11.
47. Frisch LE. Effectiveness of a case management protocol in improving follow-up and referral of Papanicolaou smears indicating cervical intraepithelial neoplasia. J Am Coll Health 1986;35:112-5.
48. Stewart DE, Lickrish GM, Sierra S, Parkin H. The effect of educational brochures on knowledge and emotional distress in women with abnormal Papanicolaou smears. Obstet Gynecol 1993;81:280-2.
49. Segnan N, Senore C, Giordano L, Ponti A, Ronco G. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies. Tumori 1998;84:348-53.